Recommendations for surveillance of Clostridium difficile-associated disease. - Wikidata - wikimedia - TriplyDB

Recommendations for surveillance of Clostridium difficile-associated disease.

Recommendations for surveillance of Clostridium difficile-associated disease.

http://www.wikidata.org/entity/Q48920404

about

Clostridium difficile infection: a review of current and emerging therapies Rational Therapy of Clostridium difficile Infections Clostridium difficile Infection in Children: Current State and Unanswered Questions Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review Epidemiology and Risk Factors for Community-Associated Clostridium difficile Infection: A Narrative Review Asymptomatic Clostridium difficile colonisation and onward transmission Prediction tools for unfavourable outcomes in Clostridium difficile infection: a systematic review The changing epidemiology of Clostridium difficile infections Automated surveillance of Clostridium difficile infections using BioSense.Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital.Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005.Conventional and alternative treatment approaches for Clostridium difficile infection Clostridium difficile Infections amongst Patients with Haematological Malignancies: A Data Linkage Study Clinical severity of Clostridium difficile PCR ribotype 027: a case-case study Use of International Classification of Diseases, Ninth Revision, Clinical Modification codes and medication use data to identify nosocomial Clostridium difficile infection.Detection of mixed populations of Clostridium difficile from symptomatic patients using capillary-based polymerase chain reaction ribotyping The relationship between phenotype, ribotype, and clinical disease in human Clostridium difficile isolates.Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study.Risk factors for Clostridium difficile infections - an overview of the evidence base and challenges in data synthesis.Surveillance for Clostridium difficile infection: ICD-9 coding has poor sensitivity compared to laboratory diagnosis in hospital patients, Singapore Decline in Clostridium difficile-associated disease rates in Singapore public hospitals, 2006 to 2008 Incidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study.Epidemiology of Clostridium difficile infection Prevalence and risk factors for asymptomatic Clostridium difficile carriage.Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection.Clostridium difficile infection in an Iranian hospital.Current status of Clostridium difficile infection epidemiology Efficacy and safety of, and patient satisfaction with, colonoscopic-administered fecal microbiota transplantation in relapsing and refractory community- and hospital-acquired Clostridium difficile infection.Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 Update.A hospital-based study of the clinical characteristics of Clostridium difficile infection in children.Hospital-acquired Clostridium difficile infections: estimating all-cause mortality and length of stay.Procalcitonin levels associate with severity of Clostridium difficile infection Validation of the chronic disease score-infectious disease (CDS-ID) for the prediction of hospital-associated clostridium difficile infection (CDI) within a retrospective cohort.Clostridium difficile infection in an endemic setting in the Netherlands Vitamin D deficiency is associated with community-acquired clostridium difficile infection: a case-control study.Clostridium difficile in the Long-Term Care Facility: Prevention and Management Characterization of cases of Clostridium difficile infection (CDI) presenting at an emergency room: molecular and clinical features differentiate community-onset hospital-associated and community-associated CDI in a tertiary care hospital.Fecal microbiota transplantation for the management of Clostridium difficile infection The systemic inflammatory response to Clostridium difficile infection Intestinal microbiota transplantation, a simple and effective treatment for severe and refractory Clostridium difficile infection.

P2860

Q26750157-5B787DD9-9DAE-439D-90E4-A1882F305C17 Q26796548-789AC8FF-F5DF-405B-B407-844B5BBDB058 Q27016320-8996DE64-9F52-4217-AD40-A70E65A8F56B Q27021390-B6270352-5A3B-4AC4-8EB5-70BC1CDA97DB Q28073805-5CDED08A-BFC1-4815-B709-9BA94F642A40 Q28661623-33357EE8-C3B0-4A9D-8787-3C7DF22BA864 Q28732437-D3923225-E318-4680-B946-5D5AF215A662 Q28750385-F7D37322-AA1A-420D-89B3-EEDD7AA16633 Q30226865-2DEDC899-0A51-4274-B0E2-89274DC6BB34 Q30228253-316C8F26-5C77-4185-AFBD-ECD66F1BB282 Q30229124-6D288A38-E3E8-4899-829F-3BE3099132FE Q30235278-6B31B407-977F-43B3-A90C-943419FBF21B Q31108764-5AE91EBF-31DC-4A9A-BB8F-AE5D6C7B6A71 Q33324391-77A1D353-019D-4AF3-B679-69A3DCDAAC2F Q33508665-7DAEE7F6-1E4C-404A-B10A-CC0347F927E4 Q33594512-D8EB079D-F6E3-433F-AA13-326308633125 Q33684178-30AD2D3B-155C-46C1-BE65-A3C0EA817D99 Q33729925-A79982A3-817F-48B1-BC52-524CC2B9C381 Q33767958-63C52FC6-E26C-41AB-936E-412A325CADD2 Q33809248-881ED943-C6B3-439D-9691-2F4EB3749835 Q33853288-50FF1ADC-4EEC-40C4-AE06-81120F592579 Q33962541-7F0DB136-7135-4010-A935-0BF17C0B83FF Q34027474-F0229173-7AA5-4861-82B8-F1D86562AB60 Q34048138-A12C47E1-C229-4632-903E-8092A55B0776 Q34141945-768AC7A4-1A54-4DCB-A6EC-0DF90E566BDD Q34205066-C693DA44-2C1E-41C9-9A41-41382881F5CC Q34285444-887593D4-6EDE-42A6-BBD3-C667C25019F9 Q34408573-5EFF0644-F147-42BA-BD16-81EEAB3F5FAF Q34419009-034D0E49-C65D-456C-A4CB-7B046579E070 Q34440654-5B236972-08E7-4C84-9DCC-1A74D7AFBC3B Q34472210-F97A919A-05AB-4FF8-8003-AA814C02313A Q34625689-0E225CAB-97A3-4059-99C6-EFC8F0148D57 Q34636604-43B0E6CD-B73A-4939-8AFF-DAC29B6D0160 Q34641408-11A96CDB-0A5D-4E33-8545-D6D572A1DA4C Q34643177-58202CF1-4736-4838-8170-C702B99E0D60 Q35065783-31440211-4097-4C55-AD5D-0F6D706666E6 Q35066802-6F34FFC2-6456-473D-AE0A-F1C759C22AC4 Q35083682-98D076BD-98F2-43BF-8CE2-36AA90063E46 Q35124315-98344D14-B884-4465-8556-0AC5E67E918B Q35211190-FE82657F-B072-4137-9C0E-CEF2AFFC0214

P2860

Recommendations for surveillance of Clostridium difficile-associated disease.

http://www.wikidata.org/entity/Q48920404

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Recommendations for surveillance of Clostridium difficile-associated disease.

@en

Recommendations for surveillance of Clostridium difficile-associated disease.

@nl

type

label

Recommendations for surveillance of Clostridium difficile-associated disease.

@en

Recommendations for surveillance of Clostridium difficile-associated disease.

@nl

prefLabel

Recommendations for surveillance of Clostridium difficile-associated disease.

@en

Recommendations for surveillance of Clostridium difficile-associated disease.

@nl

P1433

Q48920404-73915A32-A479-4794-9850-32983AD731FA

P1476

Q48920404-1D1741D2-489C-4766-875D-E4B1FAE830CA

P2093

Q48920404-45472680-8153-4D3B-9083-510A20B6CDEB

Q48920404-71BE819B-17E9-4DEB-B87A-4FACE7C681CD

Q48920404-7976801B-7C88-46EF-9B9E-CF68744861D8

Q48920404-DD903D25-DEAD-46F5-864C-C6CD69B71674

Q48920404-F339303C-1940-42D0-B55E-B0A3F212B68C

P2860

Q48920404-117232F9-792A-48DF-B3C6-72976574BC7A

Q48920404-12B972B0-445B-4855-B0B3-A01635CE1BB5

Q48920404-1F9F8A02-13C7-4838-8629-454D8A394116

Q48920404-2F10F673-FE24-4515-A03E-8800844F10C0

Q48920404-2F37F6C1-DD4B-40C3-83C7-8DF339D7CBA4

Q48920404-35CDBE8D-87C1-4955-8313-7247B0F3791C

Q48920404-3C5B0706-EF50-4E2C-97D1-7514E9D92B53

Q48920404-5B8CA6F1-2A67-4EEE-BB1E-5F7031CC7218

Q48920404-5F5FE7B6-8ACF-443C-8CE7-C5965EE0E602

Q48920404-677F29DE-840E-482F-8662-44EBA2BC9913

P304

Q48920404-40BFBAA4-4769-4486-A4F5-7E7B96FDD994

P31

Q48920404-C2AE0675-DB1D-475A-9987-E56B3BA5E78E

P356

Q48920404-D14AC2C2-203C-4AF7-A829-66FC3409DA90

P433

Q48920404-F1FDB2E7-AA8C-4084-98E7-3C676C02D962

P478

Q48920404-CCDCADCA-8AE7-4D37-A7F8-C284DD513195

P50

Q48920404-1D2AF8A9-B525-4B88-935F-543431369C18

Q48920404-C0D53559-AFF2-4ACA-902D-B8D49231E48E

P577

Q48920404-436E8F35-7605-494D-9573-122D7F81A26C

P5875

Q48920404-EE7FBC21-0F51-4151-A484-73655C432F48

P698

Q48920404-82251397-7039-4BDC-A28E-257772B3E7D8

P921

Q48920404-0BC0C601-D7C7-443D-8A6A-A2095FF9108D

P356

P1433

Infection Control and Hospital Epidemiology

P1476

Recommendations for surveillance of Clostridium difficile-associated disease.

@en

P2093

Ad Hoc Clostridium difficile Surveillance Working Group

http://www.w3.org/2001/XMLSchema#string

L Clifford McDonald

http://www.w3.org/2001/XMLSchema#string

Preeta K Kutty

http://www.w3.org/2001/XMLSchema#string

Teresa Horan

http://www.w3.org/2001/XMLSchema#string

Xiaoyan Song

http://www.w3.org/2001/XMLSchema#string

P2860

Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications

Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals.

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec

Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospitalized adults.

Risk factors for acquisition of Clostridium difficile-associated diarrhea among outpatients at a cancer hospital.

An epidemic, toxin gene-variant strain of Clostridium difficile.

Clinical practice. Antibiotic-associated diarrhea.

Clostridium difficile associated diarrhoea in hospitalised patients: onset in the community and hospital and role of flexible sigmoidoscopy.

Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982.

P304

140-145

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/511798

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Erik R Dubberke

P577

2007-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6539928

http://www.w3.org/2001/XMLSchema#string

P698

17265394

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile